Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership.
Saved in:
| Title: | Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership. |
|---|---|
| Authors: | Burke KN; Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, United States of America. Electronic address: kburke53@alumni.jh.edu., Krawczyk N; New York University Grossman School of Medicine, 550 1(st) Ave, New York, NY 10016, United States of America., Li Y; New York University School of Global Public Health, 708 Broadway, New York, NY 10003, United States of America., Byrne L; Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, United States of America., Desai IK; George Washington University Milken Institute School of Public Health, 950 New Hampshire Ave NW #2, Washington, DC 20037, United States of America., Bandara S; Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, United States of America., Feder KA; Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, United States of America. |
| Source: | Journal of substance use and addiction treatment [J Subst Use Addict Treat] 2024 Jul; Vol. 162, pp. 209351. Date of Electronic Publication: 2024 Mar 17. |
| Publication Type: | Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918541186406676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2949-8759 (Electronic) Linking ISSN: 29498759 NLM ISO Abbreviation: J Subst Use Addict Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
